Comparative study of cervical cytology in HIV-infected and non-HIV-infected women
DOI:
https://doi.org/10.18203/2320-6012.ijrms20254361Keywords:
Cervical cancer, HIV, SEAAbstract
Background: Cervical cancer remains a major preventable cause of morbidity and mortality among women worldwide, with HIV-infected women demonstrating a substantially higher susceptibility to persistent HPV infection and cervical dysplasia. This study compares cervical cytological findings in HIV-positive and HIV-negative women using Pap smear screening.
Methods: A six-month retrospective study was conducted on 200 Pap smears (100 HIV-positive, 100 HIV-negative) reported according to the 2014 Bethesda System. Unsatisfactory smears were excluded and cytological patterns were analyzed and compared.
Results: HIV-positive women showed a markedly higher prevalence of cervical abnormalities. Squamous epithelial abnormalities (SEA) were observed in 17% of HIV-positive women compared to 5% of HIV-negative women. Non-squamous abnormalities, including infectious etiologies such as bacterial vaginosis, candidiasis and trichomonas, were also significantly higher in the HIV-positive cohort (34% vs 12%). NILM rates were substantially lower among HIV-infected women (49% vs 79%).
Conclusions: HIV infection is strongly associated with increased cervical cytological abnormalities, underscoring the need for early, routine and targeted cervical screening, including Pap and HPV testing, in HIV-positive women to enable timely intervention and reduce the risk of cervical cancer.
Metrics
References
Tailor HRDP, Patel P, Bhagat V. Study of cervical pap smears in a tertiary care hospital of south Gujarat, India. Int J Res Med Sci. 2016;286–8. DOI: https://doi.org/10.18203/2320-6012.ijrms20160044
Bobdey S, Sathwara J, Jain A, Balasubramaniam G. Burden of cervical cancer and role of screening in India. Indian J Med Paediatr Oncol. 2016;37:278-85. DOI: https://doi.org/10.4103/0971-5851.195751
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. DOI: https://doi.org/10.3322/caac.21492
Toews HA. The abnormal pap smear: a rationale for follow up. Can Fam Physician. 1983;29:759-62.
Hall MT, Simms KT, Murray JM, Keane A, Nguyen DTN, Caruana M, et al. Benefits and harms of cervical screening, triage and treatment strategies in women living with HIV. Nat Med. 2023;29(12):3059–66. DOI: https://doi.org/10.1038/s41591-023-02601-3
Pendse R, Gupta S, Yu D, Sarkar S. HIV/AIDS in the South-East Asia region: progress and challenges. J Virus Eradicat. 2016;2(4):2055-640. DOI: https://doi.org/10.1016/S2055-6640(20)31092-X
Sun XW, Kuhn L, Ellerbrock TV, Chiasson MA, Bush TJ, Wright TC Jr. Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med. 1997;337(19):1343-9. DOI: https://doi.org/10.1056/NEJM199711063371903
Aboobacker KK, Shariff MH. A comparative study of conventional pap smear with liquid based cytology for early diagnosis of cervical cancer. IP Arch Cytol Histopathol Res. 2020;5(2):141-6. DOI: https://doi.org/10.18231/j.achr.2020.029
Sreenivas SMN, Menon V. Comparative study of Pap smear abnormalities in HIV infected and HIV non-infected women. Int J Reprod Contracept Obstet Gynecol. 2016;7:83–7.
Seethalakshmi GV. A comparative study of Pap smear findings among HIV positive and negative women at Government Hospital of Thoracic Medicine(GHTM), Tambaram. BMC Infect Dis. 2012;12:35. DOI: https://doi.org/10.1186/1471-2334-12-S1-P35
Ellerbrock TV, Chiasson MA, Bush TJ, Sun XW, Sawo D, Brudney K, et al. Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA. 2000;283(8):1031-7. DOI: https://doi.org/10.1001/jama.283.8.1031
Bhattacharjee DrK, Khadke DrIM. Study of cervical cytological changes in HIV patients. International J Clin Diagnos Pathol. 2021;1;4(3):1–6. DOI: https://doi.org/10.33545/pathol.2021.v4.i3a.379